Innovative Bioink Technology Revolutionizes 3D Printing of Blood Vessels
November 28, 2024 - 06:05
Researchers at the University of Twente, Netherlands, have made an advancement in bioprinting technology that could transform how we create vascularized tissues. Their innovative bioink enables precise 3D printing of blood vessels, paving the way for significant improvements in regenerative medicine and tissue engineering. This breakthrough could lead to enhanced methods for developing artificial organs and improving transplant success rates. The technology utilizes DNA-based materials to create a more accurate and functional representation of vascular structures, which are crucial for supplying nutrients and oxygen to tissues. As this research progresses, it holds the potential to greatly impact healthcare and the future of medical treatments.
MORE NEWS
August 17, 2026 - 09:31
Stronger 2026 Earnings Might Change The Case For Investing In RLX Technology (RLX)RLX Technology Inc. has reported financial results for the second quarter and the first half of 2026, showing steady gains in both sales and net income compared to the same periods last year. For...
August 16, 2026 - 19:06
Humanoid robots could patrol southern border, CEO pitches, as futuristic technology moves closer to realityA robotics company executive is proposing a futuristic solution for border security, suggesting that humanoid machines could soon handle surveillance in the most difficult stretches of the southern...
August 16, 2026 - 00:20
China shaping the future of open-source technologyThe technology that powers your device right now likely relies on open-source software. From the operating system that runs your phone to the web server that delivers this page, these free and...
August 15, 2026 - 00:14
How CVS Is Building on Its Consumer-Health Care Technology PushCVS Health is moving forward with its large-scale technology overhaul, building on a multi-billion dollar investment designed to make health care simpler for everyday customers. The company says...